Wide Ranks

CDXS

Codexis, Inc.

4.59

Top Statistics
Market Cap 373 M Forward PE -7.17 Revenue Growth 38.30 %
Current Ratio 3.21 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -96.35 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -7.10 Enterprise / Revenue 5.04 Price To Sales Trailing12 Months 5.80
Profitability
Profit Margins -96.35 % Operating Margins -129.02 %
Balance Sheet
Total Cash 90 M Total Cash Per Share 1.11 Total Debt 41 M
Total Debt To Equity 57.01 Current Ratio 3.21 Book Value Per Share 0.9020
All Measures
Short Ratio 274.00 % Message Board Id finmb_3160285 Shares Short Prior Month 2 M
Return On Equity -0.7531 City Redwood City Uuid 72094994-0589-309f-a359-b1867502319a
Previous Close 4.56 First Trade Date Epoch Utc 1 B Book Value 0.9020
Beta 2.07 Total Debt 41 M Volume 509330
Price To Book 5.09 Fifty Two Week Low 1.85 Total Cash Per Share 1.11
Total Revenue 64 M Shares Short Previous Month Date 1 B Target Median Price 7.00
Max Age 86400 Recommendation Mean 1.71 Sand P52 Week Change 0.3133
Operating Margins -129.02 % Target Mean Price 7.17 Net Income To Common -62092000
Short Percent Of Float 0.0231 Implied Shares Outstanding 81 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 677550 Average Volume10days 677550
Total Cash 90 M Next Fiscal Year End 1 B Revenue Per Share 0.9150
Held Percent Insiders 0.0222 Ebitda Margins -71.04 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 4.56
Target Low Price 3.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 3.51
Open 4.61 Free Cashflow -8124500 State CA
Dividend Yield 0.00 % Return On Assets -0.2095 Time Zone Short Name EST
Trailing Eps -0.8800 Day Low 4.47 Address1 200 Penobscot Drive
Shares Outstanding 81 M Price Hint 4 Target High Price 11.00
Website https://www.codexis.com 52 Week Change 0.9449 Average Volume 674075
Forward Eps -0.6900 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 304.00 % Is_sp_500 False Regular Market Day High 4.71
Profit Margins -96.35 % Debt To Equity 57.01 Fifty Two Week High 4.91
Day High 4.71 Shares Short 1 M Regular Market Open 4.61
Industry Key biotechnology Earnings Growth 0.00 % Enterprise To Revenue 5.04
Revenue Growth 38.30 % Shares Percent Shares Out 0.0207 Operating Cashflow -43979000
Currency USD Time Zone Full Name America/New_York Market Cap 373 M
Is_nasdaq_100 False Zip 94063 Quote Type EQUITY
Industry Biotechnology Long Name Codexis, Inc. Regular Market Day Low 4.47
Held Percent Institutions 0.7983 Current Price 4.59 Enterprise To Ebitda -7.10
Financial Currency USD Current Ratio 3.21 Gross Margins 5.51 %
Industry Disp Biotechnology Number Of Analyst Opinions 6 Country United States
Float Shares 61 M Two Hundred Day Average 3.29 Enterprise Value 325 M
Price To Sales Trailing12 Months 5.80 Forward PE -7.17 Regular Market Volume 509330
Ebitda -45779000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Codexis, Inc. discovers, develops, and sells enzymes and other proteins.

The company operates through two segments, Performance Enzymes and Novel Biotherapeutics.

It offers biocatalyst products and services.

The company also provides biocatalyst screening and protein engineering services.

In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes.

The company's platform is also used for molecular biology and in vitro diagnostic enzymes.

It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency.

The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe.

The company was incorporated in 2002 and is headquartered in Redwood City, California.